Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15199 | 726 | 40.3 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
512 | 3 | BRCA1//BRCA2//FANCONI ANEMIA | 21435 |
900 | 2 | BRCA1//BRCA2//FANCONI ANEMIA | 11301 |
15199 | 1 | CHEK2//PALB2//CHK2 | 726 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHEK2 | authKW | 2594459 | 11% | 75% | 82 |
2 | PALB2 | authKW | 1861609 | 8% | 76% | 58 |
3 | CHK2 | authKW | 911788 | 10% | 31% | 70 |
4 | CHEK2 1100DELC | authKW | 336467 | 1% | 100% | 8 |
5 | RAD51C | authKW | 319846 | 2% | 45% | 17 |
6 | CHEK2 GENE | authKW | 309699 | 1% | 82% | 9 |
7 | CHECKPOINT KINASE 2 | authKW | 309026 | 2% | 57% | 13 |
8 | BRIP1 | authKW | 221252 | 2% | 48% | 11 |
9 | CHK2 GENE | authKW | 210292 | 1% | 100% | 5 |
10 | 1100DELC | authKW | 168233 | 1% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 7696 | 53% | 0% | 385 |
2 | Genetics & Heredity | 2987 | 27% | 0% | 198 |
3 | Cell Biology | 575 | 16% | 0% | 116 |
4 | Biochemistry & Molecular Biology | 435 | 24% | 0% | 172 |
5 | Biophysics | 29 | 3% | 0% | 25 |
6 | Chemistry, Medicinal | 10 | 2% | 0% | 14 |
7 | Obstetrics & Gynecology | 5 | 2% | 0% | 12 |
8 | Medicine, Research & Experimental | 5 | 2% | 0% | 16 |
9 | Developmental Biology | 3 | 1% | 0% | 6 |
10 | Hematology | 2 | 1% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INT HEREDITARY CANC | 138659 | 4% | 11% | 29 |
2 | MARY BAAB RANDOLPH CANC | 84117 | 0% | 100% | 2 |
3 | N SCOTLAND CLIN GENET SERV | 84117 | 0% | 100% | 2 |
4 | PROGRAM CANC GENET | 76605 | 3% | 9% | 21 |
5 | ABT GYN TUMORGENET | 56076 | 0% | 67% | 2 |
6 | CANGENETEST CONSORTIUM GENET SERV | 56076 | 0% | 67% | 2 |
7 | KATHLEEN CUNNINGHAM FDN CONSORTIUM FAMILIAL B | 56076 | 0% | 67% | 2 |
8 | PENINSULA REG GENET SERV | 56076 | 0% | 67% | 2 |
9 | CANC GENET TUMOR BIOL | 48053 | 1% | 14% | 8 |
10 | BIOCHEM EXPT ONCOL | 46200 | 1% | 11% | 10 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FAMILIAL CANCER | 27671 | 3% | 3% | 24 |
2 | HEREDITARY CANCER IN CLINICAL PRACTICE | 23090 | 1% | 5% | 10 |
3 | BREAST CANCER RESEARCH AND TREATMENT | 18858 | 8% | 1% | 57 |
4 | BREAST CANCER RESEARCH | 6250 | 2% | 1% | 18 |
5 | JOURNAL OF GENETIC COUNSELING | 2272 | 1% | 1% | 6 |
6 | BALKAN JOURNAL OF MEDICAL GENETICS | 1747 | 0% | 1% | 3 |
7 | GENETICS IN MEDICINE | 1656 | 1% | 0% | 8 |
8 | CANCER GENETICS | 1621 | 1% | 1% | 4 |
9 | MEDIZINISCHE GENETIK | 1619 | 0% | 1% | 3 |
10 | JOURNAL OF MEDICAL GENETICS | 1403 | 2% | 0% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHEK2 | 2594459 | 11% | 75% | 82 | Search CHEK2 | Search CHEK2 |
2 | PALB2 | 1861609 | 8% | 76% | 58 | Search PALB2 | Search PALB2 |
3 | CHK2 | 911788 | 10% | 31% | 70 | Search CHK2 | Search CHK2 |
4 | CHEK2 1100DELC | 336467 | 1% | 100% | 8 | Search CHEK2+1100DELC | Search CHEK2+1100DELC |
5 | RAD51C | 319846 | 2% | 45% | 17 | Search RAD51C | Search RAD51C |
6 | CHEK2 GENE | 309699 | 1% | 82% | 9 | Search CHEK2+GENE | Search CHEK2+GENE |
7 | CHECKPOINT KINASE 2 | 309026 | 2% | 57% | 13 | Search CHECKPOINT+KINASE+2 | Search CHECKPOINT+KINASE+2 |
8 | BRIP1 | 221252 | 2% | 48% | 11 | Search BRIP1 | Search BRIP1 |
9 | CHK2 GENE | 210292 | 1% | 100% | 5 | Search CHK2+GENE | Search CHK2+GENE |
10 | 1100DELC | 168233 | 1% | 100% | 4 | Search 1100DELC | Search 1100DELC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ANTONI, L , SODHA, N , COLLINS, I , GARRETT, MD , (2007) CHK2 KINASE: CANCER SUSCEPTIBILITY AND CANCER THERAPY - TWO SIDES OF THE SAME COIN?.NATURE REVIEWS CANCER. VOL. 7. ISSUE 12. P. 925 -936 | 84 | 65% | 153 |
2 | NEVANLINNA, H , BARTEK, J , (2006) THE CHEK2 GENE AND INHERITED BREAST CANCER SUSCEPTIBILITY.ONCOGENE. VOL. 25. ISSUE 43. P. 5912 -5919 | 58 | 82% | 92 |
3 | DESRICHARD, A , BIDET, Y , UHRHAMMER, N , BIGNON, YJ , (2011) CHEK2 CONTRIBUTION TO HEREDITARY BREAST CANCER IN NON-BRCA FAMILIES.BREAST CANCER RESEARCH. VOL. 13. ISSUE 6. P. - | 46 | 75% | 18 |
4 | NAROD, SA , (2010) TESTING FOR CHEK2 IN THE CANCER GENETICS CLINIC: READY FOR PRIME TIME?.CLINICAL GENETICS. VOL. 78. ISSUE 1. P. 1 -7 | 43 | 80% | 29 |
5 | ANGELOVA, SG , KRASTEVA, ME , GOSPODINOVA, ZI , GEORGIEVA, EI , (2012) CHEK2 GENE ALTERATIONS INDEPENDENTLY INCREASE THE RISK OF DEATH FROM BREAST CANCER IN BULGARIAN PATIENTS.NEOPLASMA. VOL. 59. ISSUE 6. P. 622-630 | 44 | 77% | 3 |
6 | RASHID, MU , MUHAMMAD, N , FAISAL, S , AMIN, A , HAMANN, U , (2013) CONSTITUTIONAL CHEK2 MUTATIONS ARE INFREQUENT IN EARLY-ONSET AND FAMILIAL BREAST/OVARIAN CANCER PATIENTS FROM PAKISTAN.BMC CANCER. VOL. 13. ISSUE . P. - | 38 | 84% | 5 |
7 | MOHAMAD, S , LSA, NM , MUHAMMAD, R , EMRAN, NA , KITAN, NM , KANG, P , KANG, IN , TAID, NAM , TEO, SH , AKMAL, SN , (2015) LOW PREVALENCE OF CHEK2 GENE MUTATIONS IN MULTIETHNIC COHORTS OF BREAST CANCER PATIENTS IN MALAYSIA.PLOS ONE. VOL. 10. ISSUE 1. P. - | 33 | 94% | 0 |
8 | CECENER, G , ESKILER, GG , EGELI, U , TUNCA, B , ALEMDAR, A , GOKGOZ, S , TASDELEN, I , (2016) ASSOCIATION OF PALB2 SEQUENCE VARIANTS WITH THE RISK OF EARLY-ONSET BREAST CANCER IN PATIENTS FROM TURKEY.MOLECULAR BIOLOGY REPORTS. VOL. 43. ISSUE 11. P. 1273 -1284 | 34 | 85% | 0 |
9 | CATUCCI, I , MILGROM, R , KUSHNIR, A , LAITMAN, Y , PALUCH-SHIMON, S , VOLORIO, S , FICARAZZI, F , BERNARD, L , RADICE, P , FRIEDMAN, E , ET AL (2012) GERMLINE MUTATIONS IN BRIP1 AND PALB2 IN JEWISH HIGH CANCER RISK FAMILIES.FAMILIAL CANCER. VOL. 11. ISSUE 3. P. 483 -491 | 36 | 82% | 15 |
10 | WEISCHER, M , BOJESEN, SE , ELLERVIK, C , TYBJAERG-HANSEN, A , NORDESTGAARD, BG , (2008) CHEK2* 1100DELC GENOTYPING FOR CLINICAL ASSESSMENT OF BREAST CANCER RISK: META-ANALYSES OF 26,000 PATIENT CASES AND 27,000 CONTROLS.JOURNAL OF CLINICAL ONCOLOGY. VOL. 26. ISSUE 4. P. 542-548 | 31 | 91% | 98 |
Classes with closest relation at Level 1 |